Immuno-Oncology Conference is organized by SMi Group and will be held during Sep 26 - 27, 2018 at Copthorne Tara Hotel London Kensington, London, England, United Kingdom.
This event will draw together different, key facets of the rapidly evolving field to propagate invigorating and thought-provoking discussions between industry leaders and inform and update delegates on current key areas for development, on future potential therapies advancements and provide revisions of regulations.
The Immuno-Oncology Conference will focus on a few key areas of the field with a representation of the whole industry under each area. These areas will be drawn together to look towards the future of Immuno-oncology and how the field can progress.
Benifits of Attending
• Learn about targeting immune checkpoints with Humabody VH Therapeutics
• Discover the recent advances in providing durable disease control with Keytruda as an anti-cancer therapy
• Discuss the tumour mutation burden and the potential of its use as an indication of treatment choice
• Develop an understanding of unwanted immunogenicity and functionality testing of immuno-oncology drugs
• Gain insight into new techniques, such as the emerging applications of liquid biopsies, in Immuno-Oncology
At the SMi's Immuno-Oncology Conference you will get: Networking: We keep networking at the forefront when it comes to our attendees. 5+ hours of pure networking guaranteed Agenda: A valuable time is spent to discover the latest trends and hottest topics in the industry to provide the best possible agenda for our attendees. 15+ engaging presentations/case studies/keynote addresses Speakers: Top representation of industry leaders. 15+ leading experts in Immuno-Oncology field Workshops: Carefully selected topics for further on-sight training. 2 pre-conference workshops with in-depth knowledge on specific topics
Additional details will be posted as soon as they are available.